301331 Enwei Pharmaceutical
- 23.73
- +0.82+3.58%
About Enwei Pharmaceutical Company
The company was founded in 1986 and is mainly engaged in R&D, production and sales of proprietary Chinese medicines and chemicals. It is committed to combining traditional Chinese medicine with modern medical technology to establish a traditional Chinese medicine industry with deep Chinese characteristics around life science. Listed on A-shares on the Shenzhen Stock Exchange on September 21, 2022. The company is mainly engaged in R&D, production and sales of proprietary Chinese medicines and chemicals, focusing on gynecological products, pediatric medicine, respiratory medicine and other fields. Main products: Jieryin lotion, Huajiji oral liquid, Shanmai spleen oral solution, Agastache Zhengqi Tonic, Liuwei Dihuang capsules, compound Yinqiao aminamine capsules, compound aminophenolamine tablets.
Company Profile
Company Executives
- Name
- Position
- Salary
- yongjiang xue
- Chairman, directors, Chief Executive Officer (CEO), Member of the Nomination and Remuneration Committee, Chairman of the Strategy and Development Committee
- 1.40M
- gang xue
- Vice Chairman, Directors, General Manager
- 726.00K
- yan zhuang
- Directors, Deputy General Manager, Member of the Strategy and Development Committee
- 422.00K
- weihong xue
- Directors, Audit Committee Member
- --
- ya liu
- Independent Directors, Chairman of the Audit Committee
- --
- gang peng
- Independent Directors, Audit Committee Member, Chairman of the Nomination and Remuneration Committee
- --
- chun li
- Independent Directors, Member of the Strategy and Development Committee, Member of the Nomination and Remuneration Committee
- --
- dawei hu
- Board Secretary, VP, Chief Financial Officer
- 443.70K
- yongbao tan
- Securities Affairs Representative
- --
- zhanghong du
- Chairman of the Supervisory Board, Auditors
- 120.30K
- li yi
- Auditors
- --
- lei chen
- VP
- 471.00K
- li liu
- Employee Supervisors
- 147.80K
Analysis
Price Target
No Data
No Data